| 國立成功大學 |
2023 |
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis
|
Ahmadi, Ahmadi A.R.;Song, G.;Gao, T.;Ma, J.;Han, X.;Hu, M.-W.;Cameron, A.M.;Wesson, R.N.;Philosophe, B.;Ottmann, S.;King, E.;Gurakar, A.;Qi, L.;Peiffer, B.;Burdick, J.;Anders, R.;Zhou, Zhou Z.;Lu, H.;Feng, D.;Chen, Chen C.-S.;Qian, J.;Gao, B.;Zhu, H.;Sun, Z. |
| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Association between prior use of anti-diabetic medication and breast cancer stage at diagnosis
|
Fahim S.M.; Hsu C.-H.; FANG-JU LIN; Qian J.; Chou C. |
| 臺大學術典藏 |
2021-07-03T03:34:18Z |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
|
Toh H.C.; PEI-JER CHEN; Carr B.I.; Knox J.J.; Gill S.; Ansell P.; McKeegan E.M.; Dowell B.; Pedersen M.; Qin Q.; Qian J.; Scappaticci F.A.; Ricker J.L.; Carlson D.M.; Yong W.P. |
| 臺大學術典藏 |
2021-07-03T03:33:57Z |
Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial
|
Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S. |
| 臺大學術典藏 |
2021-06-15T03:11:59Z |
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Park D.I.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:58Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:58Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:57Z |
Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:45Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
|
Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI; Ahuja V.; Chen M.; Hu P.-J.; Andoh A.; Kim H.J.; Yang S.-K.; Watanabe M.; Ng S.C.; Hibi T.; Hilmi I.N.; Suzuki Y.; Han D.S.; Leung W.K.; Sollano J.; Ooi C.J.; Qian J. |
| 臺大學術典藏 |
2020-12-28T06:25:39Z |
Chronic Total Occlusion Wiring: A State-of-the-Art Guide From The Asia Pacific Chronic Total Occlusion Club
|
Wu E.B.; Tsuchikane E.; Lo S.; Lim S.T.; Ge L.; Chen J.-Y.; Qian J.; Lee S.-W.; HSIEN-LI KAO; Harding S.A. |
| 臺大學術典藏 |
2020-12-28T06:25:36Z |
Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club
|
Wu E.B.; Brilakis E.S.; Lo S.; Kalyanasundaram A.; Mashayekhi K.; HSIEN-LI KAO; Lim S.-T.; Ge L.; Chen J.-Y.; Qian J.; Lee S.-W.; Harding S.A.; Tsuchikane E. |
| 臺大學術典藏 |
2020-12-25T08:38:31Z |
Chronic Total Occlusion Wiring: A State-of-the-Art Guide From The Asia Pacific Chronic Total Occlusion Club
|
Harding S.A.; HSIEN-LI KAO; Wu E.B.; Tsuchikane E.; Lo S.; Lim S.T.; Ge L.; Chen J.-Y.; Qian J.; Lee S.-W. |
| 臺大學術典藏 |
2020-12-25T08:38:28Z |
Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club
|
Chen J.-Y.; Ge L.; Lim S.-T.; HSIEN-LI KAO; Mashayekhi K.; Kalyanasundaram A.; Lo S.; Brilakis E.S.; Wu E.B.; Qian J.; Lee S.-W.; Harding S.A.; Tsuchikane E. |
| 臺大學術典藏 |
2020-12-22T03:29:35Z |
Notch signaling controls the balance of ciliated and secretory cell fates in developing airways
|
Cardoso W.V.; Lu J.; Qian J.; Izvolsky K.I.; Vasconcelos M.; PO-NIEN TSAO |
| 臺大學術典藏 |
2020-10-20T01:45:44Z |
Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling
|
Hayward S.D.; Manda S.S.; Pandey A.; Zhang K.; Lv D.-W.; Wu X.; Gowda H.; Qian J.; Wan J.; Shaw P.G.; TAI-CHUNG HUANG; Nirujogi R.S.; Pinto S.M.; Li R.; Liao G. |
| 臺大學術典藏 |
2020-10-14T07:24:35Z |
Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Hilmi I.N.; Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2020-10-14T07:24:35Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Ran Z.; Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2020-08-12T01:40:05Z |
Functional dissection of a HECT ubiquitin E3 ligase
|
JIN-YING LU; Lin Y.-Y.; Qian J.; Tao S.-C.; Zhu J.; Pickart C.; Zhu H. |
| 臺大學術典藏 |
2020-05-26T09:27:15Z |
Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
|
Hensing T; Lee C; Gupta N; Pradhan R; Qian J; Qin Q; Scappaticci F.A; Ricker J.L; Carlson D.M; Soo R.A.; Tan E.-H;Goss G.D;Salgia R;Besse B;Gandara D.R;Hanna N.H;Chih-Hsin Yang;Thertulien R;Wertheim M;Mazieres J;Hensing T;Lee C;Gupta N;Pradhan R;Qian J;Qin Q;Scappaticci F.A;Ricker J.L;Carlson D.M;Soo R.A.; Tan E.-H; Goss G.D; Salgia R; Besse B; Gandara D.R; Hanna N.H; CHIH-HSIN YANG; Thertulien R; Wertheim M; Mazieres J |
| 臺大學術典藏 |
2020-01-13T08:21:24Z |
The role of hydrodynamic instability in flame-vortex interaction
|
Pan, K.L.; Qian, J.; Law, C.K.; Shyy, W.; KUO-LONG PAN |
| 臺大學術典藏 |
2020 |
Retrograde Versus Antegrade Approach for Coronary Chronic Total Occlusion in an Algorithm-Driven Contemporary Asia-Pacific Multicentre Registry: Comparison of Outcomes
|
HSIEN-LI KAO; Qian J.; Lee S.-W.; Chen J.-Y.; Lim S.T.; Lo S.; Harding S.A.; Ge L.; Tsuchikane E.; Wu E.B.; Yan B.P.Y. |
| 臺大學術典藏 |
2020 |
Retrograde Versus Antegrade Approach for Coronary Chronic Total Occlusion in an Algorithm-Driven Contemporary Asia-Pacific Multicentre Registry: Comparison of Outcomes
|
Wu E.B.; Yan B.P.Y.; HSIEN-LI KAO; Qian J.; Lee S.-W.; Chen J.-Y.; Lim S.T.; Lo S.; Tsuchikane E.; Ge L.; Harding S.A. |
| 臺大學術典藏 |
2020 |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
|
Leung W.K.; Han D.S.; Suzuki Y.; Hilmi I.N.; Hibi T.; Ng S.C.; Watanabe M.; Yang S.-K.; Kim H.J.; Hu P.-J.; Andoh A.; Chen M.; Ahuja V.; Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI; Sollano J.; Ooi C.J.; Qian J. |
| 臺大學術典藏 |
2018 |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Watanabe M.; Sugano K.; Suzuki Y.; Andoh A.; Matsuoka K.; Hu P.-J.; Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2018 |
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Ran Z.; Kim H.J.; Han D.S.; Jeen Y.T.; Hilmi I.N.; Banerjee R.; SHU-CHEN WEI; Ooi C.J.; Park D.I.I.; Hisamatsu T.; Chen M.; Ng S.C.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
